Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acarbose for postprandial hypotension in older adults with type 2 diabetes
ChiCTR-IPR-15006177Phase 4Completed
- Sponsor
- Beijing Hospital
- Start
- Sep 2012
- Modality
- Microbiome-Derived Products → Microbiome Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of acarbose in Postprandial hypotension (PPH) (3 arms), sponsored by Beijing Hospital. Primary endpoints: postprandial blood pressure, heart rate and 4 more. Started Sep 2012; status: completed.
02
Drugs
acarbose
03
Conditions
Postprandial hypotension (PPH)
Beyond the preview
Go deeper on ChiCTR-IPR-15006177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006177.